Predictors of bowel damage in the long-term progression of Crohn's disease.

Bowel damage Crohn’s disease Inflammatory bowel disease Lémann index Magnetic resonance imaging

Journal

World journal of clinical cases
ISSN: 2307-8960
Titre abrégé: World J Clin Cases
Pays: United States
ID NLM: 101618806

Informations de publication

Date de publication:
26 Nov 2022
Historique:
received: 14 09 2022
revised: 06 10 2022
accepted: 31 10 2022
entrez: 9 12 2022
pubmed: 10 12 2022
medline: 10 12 2022
Statut: ppublish

Résumé

Crohn's disease (CD) is a chronic inflammatory bowel disorder that progresses to bowel damage (BD) over time. An image-based index, the Lémann index (LI), has been developed to measure cumulative BD. To characterize the long-term progression of BD in CD based on changes in the LI and to determine risk factors for long-term progression. This was a single-center longitudinal cohort study. Patients who had participated in prospective studies on the accuracy of magnetic resonance imaging using endoscopy as a gold standard and who had a follow-up of at least 5 years were re-evaluated after 5-12 years. Seventy-two patients were included. LI increased in 38 patients (52.8%), remained unchanged in 9 patients (12.5%), and decreased in 25 patients (34.7%). The small bowel score and surgery subscale significantly increased ( BD, as assessed by the LI, progressed in half of the patients with CD over a period of 5-12 years. The main determinants of BD progression were ileal location, stricturing/fistulizing phenotype, and disease duration.

Sections du résumé

BACKGROUND BACKGROUND
Crohn's disease (CD) is a chronic inflammatory bowel disorder that progresses to bowel damage (BD) over time. An image-based index, the Lémann index (LI), has been developed to measure cumulative BD.
AIM OBJECTIVE
To characterize the long-term progression of BD in CD based on changes in the LI and to determine risk factors for long-term progression.
METHODS METHODS
This was a single-center longitudinal cohort study. Patients who had participated in prospective studies on the accuracy of magnetic resonance imaging using endoscopy as a gold standard and who had a follow-up of at least 5 years were re-evaluated after 5-12 years.
RESULTS RESULTS
Seventy-two patients were included. LI increased in 38 patients (52.8%), remained unchanged in 9 patients (12.5%), and decreased in 25 patients (34.7%). The small bowel score and surgery subscale significantly increased (
CONCLUSION CONCLUSIONS
BD, as assessed by the LI, progressed in half of the patients with CD over a period of 5-12 years. The main determinants of BD progression were ileal location, stricturing/fistulizing phenotype, and disease duration.

Identifiants

pubmed: 36483818
doi: 10.12998/wjcc.v10.i33.12208
pmc: PMC9724529
doi:

Types de publication

Journal Article

Langues

eng

Pagination

12208-12220

Informations de copyright

©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: Dr. Rimola reports grants from Abbvie, personal fees from Alimentiv, personal fees from Janssen, personal fees from Takeda, non-financial support from Gilead and from Agumab during the conduct of the study.

Références

Gastroenterology. 2015 Jan;148(1):52-63.e3
pubmed: 25241327
United European Gastroenterol J. 2020 May;8(4):410-417
pubmed: 32213030
Aliment Pharmacol Ther. 2020 May;51(9):889-898
pubmed: 32221985
Aliment Pharmacol Ther. 2020 Nov;52(10):1563-1573
pubmed: 32886809
Open Med (Wars). 2019 Nov 07;14:785-791
pubmed: 31737782
Gastroenterology. 2021 Sep;161(3):853-864.e13
pubmed: 34052277
Clin Gastroenterol Hepatol. 2015 Sep;13(9):1633-40.e3
pubmed: 25766650
Clin Gastroenterol Hepatol. 2018 Jan;16(1):75-82.e5
pubmed: 28694130
Scand J Gastroenterol. 2019 Nov;54(11):1339-1345
pubmed: 31692395
Dig Liver Dis. 2017 May;49(5):490-494
pubmed: 28233685
Gut. 2015 Sep;64(9):1397-402
pubmed: 25516418
Gastroenterology. 2010 Oct;139(4):1147-55
pubmed: 20637205
J Crohns Colitis. 2015 Aug;9(8):633-9
pubmed: 25958059
Dig Liver Dis. 2017 Feb;49(2):175-180
pubmed: 27864028
J Crohns Colitis. 2010 Feb;4(1):7-27
pubmed: 21122488

Auteurs

Agnes Fernández-Clotet (A)

Department of Gastroenterology, Hospital Clinic, Barcelona 08036, Spain.
Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBEREHD, Madrid 28029, Spain.

Julian Panés (J)

Department of Gastroenterology, Hospital Clinic, Barcelona 08036, Spain.
Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBEREHD, Madrid 28029, Spain.

Elena Ricart (E)

Department of Gastroenterology, Hospital Clinic, Barcelona 08036, Spain.
Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBEREHD, Madrid 28029, Spain.

Jesús Castro-Poceiro (J)

Department of Gastroenterology, Hospital Clinic, Barcelona 08036, Spain.
Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBEREHD, Madrid 28029, Spain.

Maria Carme Masamunt (MC)

Department of Gastroenterology, Hospital Clinic, Barcelona 08036, Spain.
Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBEREHD, Madrid 28029, Spain.

Sonia Rodríguez (S)

Department of Radiology, Hospital Clinic, Barcelona 08036, Spain.

Berta Caballol (B)

Department of Gastroenterology, Hospital Clinic, Barcelona 08036, Spain.
Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBEREHD, Madrid 28029, Spain.

Ingrid Ordás (I)

Department of Gastroenterology, Hospital Clinic, Barcelona 08036, Spain.
Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBEREHD, Madrid 28029, Spain.

Jordi Rimola (J)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBEREHD, Madrid 28029, Spain.
Department of Radiology, Hospital Clinic, Barcelona 08036, Spain. jrimola@clinic.cat.

Classifications MeSH